Asia Pacific Aesthetics Market Research Report: Procedures (Surgical Aesthetic Procedure), Procedures (Aesthetic Implants), Application (Breast Enhancement, Scar Treatment, Tattoo Removal), End User (Dermatology Clinics, Cosmetic Clinics) – Forecast Till 2027
The Asia Pacific is a lucrative market for aesthetics and the developments in cosmetic surgeries is further expected to propel the expansion of the market. As per the analysis offered by Market Research Future (MRFR), the Asia Pacific aesthetics market is presumed to expand at a CAGR of 11.5% during the forecast period 2017 to 2023.
The region has been witnessing a rise in the burden of disorders such as alopecia, acne, obesity, etc. which has fueled the demand for cosmetic surgeries. Furthermore, the influence of the media industry is also anticipated to favor the expansion of the Asia Pacific aesthetics market.
Asia Pacific resonates growth potential which is likely to attract investments from the global leaders in the market. Furthermore, robust branding practices are forecasted to create awareness about the availability of cosmetic surgeries, thus, augmenting the Asia Pacific aesthetics market. The advent of minimally invasive aesthetic surgeries has opened new avenues of growth potential and is projected to aid the proliferation of the market.
On the basis of the procedures, the Asia Pacific aesthetics market is segmented into surgical aesthetic procedures and nonsurgical aesthetic procedures. The surgical aesthetic procedures segment has been sub-segmented into breast augmentation, liposuction, tummy tuck, breast lift, dermabrasion, eyelid surgery, and others. The nonsurgical aesthetic procedures segment has been further sub-segmented into hyaluronic acid, botulinum toxin, hair removal, chemical peel, photorejuvenation (IPL), microdermabrasion, and others.
On the basis of the product, the Asia Pacific aesthetics market has been segmented into aesthetic implants, laser, and energy based devices, skin tightening and body contouring devices, and others. The skin tightening and body contouring devices segment have been further sub-segmented into liposuction devices, cryolipolysis technology, cellulite reduction devices, anti-aging device, and others. The aesthetic implants segment has been sub-segmented into breast implants, buttock augmentation, dental implants, transdermal implants, and others.
On the basis of the application, the Asia Pacific aesthetics market has been segmented into tattoo removal, facial & body contouring, breast enhancement, scar treatment, facial & skin rejuvenation, reconstructive surgery, vaginal rejuvenation, and others.
On the basis of the end-user, the Asia Pacific aesthetics market is segmented into dermatology clinics, cosmetic centers, hospitals & clinics, and others.
Asia Pacific aesthetics market, by region, is segmented into China, India, Japan, Australia, and the Rest of Asia Pacific. Among these, Japan is projected to secure the principal position in the marketplace. As per the International Trade Administration in 2015, its per capita cosmetic expenditure is estimated to be USD 174. The high cosmetic expenditure is one of the primary drivers of market growth in the country.
India stands at the second spot in the Asia Pacific aesthetics market. According to the Indian Journal of Pediatric Dermatology in 2017, around 200 – 300 million people suffer from acne issues in the nation, thus, making it a major country-level market for aesthetics.
China is likely to be favored by the growing population base and secures the third spot. Meanwhile, Australia is anticipated to hold the least share of the Asia Pacific aesthetics market.
The key players operating in the Asia Pacific aesthetics market are Cutera (U.S.), ALLERGAN (Ireland), Lumenis (Israel), Alma Lasers (Israel), Syneron Medical Ltd. (U.S.), Cynosure, Inc. (U.S.), Galderma S.A. (Switzerland), PhotoMedex, Inc. (U.S.), Solta Medical, Inc. (Canada), Mentor Worldwide LLC (U.S), ZELTIQ Aesthetics, Inc. (U.S.), Sanofi (France), Merz Pharma (Germany), Johnson & Johnson Services, Inc. (U.S.), and Integra Lifesciences (U.S.).
In September 2019, Huons, a subsidiary of Huons Global, has signed a contract with a Chinese firm, Imeik Technology Development, for exporting the company’s botulinum toxin (BTX) product, Hutox.
In June 2018, a global event’s organizer, Comexposium, has acquired International Master Course on Aging Science (IMCAS) events which are headquartered in Paris with an additional office in Hong Kong
You may also be interested in..
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312